Description
2022 PUBLIC LAW PRICING UPDATES
Base award description: BPA FOR HETLIOZ
First action · last action
2017-10-25 · 2021-12-22
Transactions
13
First transaction's obligation
$0
Base + all options value (sum of deltas)
$1,425,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70102
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 13 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-10-25+$0= $0
- Mod P000012017-12-15+$0= $0
- Mod P000022018-10-10+$0= $0
- Mod P000032018-11-26+$0= $0
- Mod P000042018-12-31+$0= $0
- Mod P000052019-09-25+$0= $0
- Mod P000062019-12-23+$0= $0
- Mod P000072020-01-06+$0= $0
- Mod P000082020-09-03+$0= $0
- Mod P000092020-12-17+$0= $0
- Mod P000102021-04-27+$0= $0
- Mod P000112021-08-26+$0= $0
- Mod P000122021-12-22+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-10-25 | +$0 | $0 | BPA FOR HETLIOZ |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-12-15 | +$0 | $0 | 2018 PUBLIC LAW UPDATES. |
| Mod P00002· EXERCISE AN OPTION | 2018-10-10 | +$0 | $0 | EXERCISE OPTION YR1 |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2018-11-26 | +$0 | $0 | INCORPORATE REVISED HETLIOZ ORDERING FORMS |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-12-31 | +$0 | $0 | 2019 PUBLIC LAW PRICING UPDATES |
| Mod P00005· EXERCISE AN OPTION | 2019-09-25 | +$0 | $0 | EXERCISE OPTION YEAR 2 |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-12-23 | +$0 | $0 | 2020 PUBLIC LAW UPDATES |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-01-06 | +$0 | $0 | 2020 PUBLIC LAW UPDATES CORRECTION |
| Mod P00008· EXERCISE AN OPTION | 2020-09-03 | +$0 | $0 | EXERCISE OPTION YEAR 3 |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-12-17 | +$0 | $0 | 2021 PUBLIC LAW PRICING UPDATE |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-04-27 | +$0 | $0 | HETLIOZ PRODUCT ADDITION. |
| Mod P00011· EXERCISE AN OPTION | 2021-08-26 | +$0 | $0 | EXERCISE OPTION YEAR 4 |
| Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-22 | +$0 | $0 | 2022 PUBLIC LAW PRICING UPDATES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NG5JU1TQ3379)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026F0025 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $26,344 | FY2026 |
| 36C26025F0002 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $131,068 | FY2025 |
| 36E79724A0032 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36F79724D0191 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C26024F0173 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $154,049 | FY2024 |
| 36C26023F0431 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $77,799 | FY2023 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797E17A0008_3600 · retrieved 2026-09-27.